<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Chronic B-Cell | Clinical Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of Chronic/Mature B-Cell Leukemia/Lymphoma  Definition: A diverse group of lymphoid neoplasms arising from mature B lymphocytes. These are generally indolent (slow-growing) malignancies,...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Chronic B-Cell | Clinical Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of Chronic/Mature B-Cell Leukemia/Lymphoma  Definition: A diverse group of lymphoid neoplasms arising from mature B lymphocytes. These are generally indolent (slow-growing) malignancies,...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Chronic B-Cell | Clinical Hematology">
<meta name="twitter:description" content="Overview of Chronic/Mature B-Cell Leukemia/Lymphoma  Definition: A diverse group of lymphoid neoplasms arising from mature B lymphocytes. These are generally indolent (slow-growing) malignancies,...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><!-- Google tag (gtag.js) --><script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Clinical Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="active" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Hematology">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="chronic-b-cell" class="section level1 unnumbered">
<h1>Chronic B-Cell<a class="anchor" aria-label="anchor" href="#chronic-b-cell"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-chronicmature-b-cell-leukemialymphoma" class="section level2 unnumbered">
<h2>
<strong>Overview of Chronic/Mature B-Cell Leukemia/Lymphoma</strong><a class="anchor" aria-label="anchor" href="#overview-of-chronicmature-b-cell-leukemialymphoma"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A diverse group of lymphoid neoplasms arising from mature B lymphocytes. These are generally indolent (slow-growing) malignancies, though some can be more aggressive</li>
<li>
<strong>Key Features:</strong>
<ul>
<li>Clonal Proliferation: Proliferation of a single, abnormal clone of B cells</li>
<li>Mature B-Cell Phenotype: Cells express markers of mature B cells (e.g., CD19, CD20)</li>
<li>Variable Morphology: Cells may have variable size, shape, and nuclear features</li>
<li>Lymph Node and Bone Marrow Involvement: Often involve lymph nodes, spleen, liver, and bone marrow</li>
</ul>
</li>
<li>
<strong>Classification:</strong> The World Health Organization (WHO) classification is used to categorize these disorders based on clinical, morphological, immunophenotypic, and genetic features</li>
<li>
<strong>Common Disorders Included:</strong>
<ul>
<li>Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)</li>
<li>Prolymphocytic Leukemia (PLL)</li>
<li>Hairy Cell Leukemia (HCL)</li>
<li>Burkitt Lymphoma</li>
<li>Waldenström Macroglobulinemia (WM)</li>
</ul>
</li>
</ul>
</div>
<div id="chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-cllsll" class="section level2 unnumbered">
<h2>
<strong>Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)</strong><a class="anchor" aria-label="anchor" href="#chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-cllsll"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> CLL and SLL are considered the same disease, differing primarily in the site of involvement. CLL primarily involves the blood and bone marrow, while SLL primarily involves the lymph nodes</li>
<li>
<strong>Diagnostic Criteria:</strong>
<ul>
<li>Peripheral Blood:
<ul>
<li>Sustained absolute lymphocytosis (≥5.0 x 10^9/L) with a characteristic immunophenotype</li>
<li>Smudge cells are often present on the peripheral blood smear</li>
</ul>
</li>
<li>Bone Marrow (Usually Not Required for Diagnosis):
<ul>
<li>Lymphocytic infiltration</li>
</ul>
</li>
<li>Immunophenotype (by Flow Cytometry):
<ul>
<li>CD5+, CD19+, CD20 (dim), CD23+, sIg (weak), CD10-</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Pathophysiology:</strong>
<ul>
<li>Clonal proliferation of mature, usually naive B cells that express CD5 (a T-cell marker)</li>
<li>Cells accumulate in the bone marrow, lymph nodes, spleen, and blood</li>
<li>Abnormal B cells are relatively immunocompetent, leading to increased susceptibility to infections</li>
</ul>
</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Often asymptomatic at diagnosis</li>
<li>Lymphadenopathy (swollen lymph nodes)</li>
<li>Splenomegaly (enlarged spleen)</li>
<li>Fatigue</li>
<li>Weight loss</li>
<li>Night sweats</li>
<li>Increased susceptibility to infections</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>CBC:
<ul>
<li>Lymphocytosis (often marked, &gt;20 x 10^9/L)</li>
<li>Anemia (in advanced stages)</li>
<li>Thrombocytopenia (in advanced stages)</li>
</ul>
</li>
<li>Peripheral Blood Smear:
<ul>
<li>Small, mature lymphocytes with condensed chromatin</li>
<li>Smudge cells: Fragile lymphocytes that rupture during smear preparation</li>
</ul>
</li>
<li>Flow Cytometry Immunophenotyping:
<ul>
<li>Confirms the diagnosis and differentiates CLL from other lymphoproliferative disorders</li>
<li>CD5+, CD19+, CD20 (dim), CD23+, sIg (weak), CD10-</li>
</ul>
</li>
<li>Cytogenetic Analysis:
<ul>
<li>Used to assess prognosis</li>
<li>Common abnormalities: del(13q14), trisomy 12, del(11q22.3), del(17p13.1)</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Staging:</strong>
<ul>
<li>Rai Staging System (for CLL): Based on the presence and extent of lymphadenopathy, splenomegaly, hepatomegaly, anemia, and thrombocytopenia</li>
<li>Binet Staging System (for CLL): Similar to Rai staging, but based on the number of involved lymphoid areas</li>
</ul>
</li>
<li>
<strong>Prognosis:</strong>
<ul>
<li>Variable; some patients have an indolent course, while others have a more aggressive disease</li>
<li>Prognostic factors: Stage, cytogenetic abnormalities, immunoglobulin heavy chain variable region (IGHV) mutation status</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Watch and Wait: Many patients with early-stage CLL do not require immediate treatment</li>
<li>Chemoimmunotherapy:
<ul>
<li>Combination of chemotherapy drugs (e.g., fludarabine, cyclophosphamide) and monoclonal antibodies (e.g., rituximab, obinutuzumab)</li>
</ul>
</li>
<li>Targeted Therapies:
<ul>
<li>BTK Inhibitors: Ibrutinib, acalabrutinib
<ul>
<li>Inhibit Bruton’s tyrosine kinase (BTK), a key signaling molecule in B-cell receptor pathway</li>
</ul>
</li>
<li>BCL-2 Inhibitors: Venetoclax
<ul>
<li>Inhibits BCL-2, an anti-apoptotic protein</li>
</ul>
</li>
<li>PI3K Inhibitors:
<ul>
<li>Copanlisib, duvelisib</li>
</ul>
</li>
</ul>
</li>
<li>CAR T-Cell Therapy:
<ul>
<li>Chimeric antigen receptor (CAR) T-cell therapy: Genetically engineered T cells that target CD19 on B cells</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="prolymphocytic-leukemia-pll" class="section level2 unnumbered">
<h2>
<strong>Prolymphocytic Leukemia (PLL)</strong><a class="anchor" aria-label="anchor" href="#prolymphocytic-leukemia-pll"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A rare, aggressive B-cell or T-cell neoplasm characterized by a high white blood cell count and a predominance of prolymphocytes in the peripheral blood</li>
<li>
<strong>Types:</strong>
<ul>
<li>B-PLL: More common; derived from mature B cells</li>
<li>T-PLL: Less common; derived from mature T cells</li>
</ul>
</li>
<li>
<strong>Pathophysiology:</strong>
<ul>
<li>Clonal proliferation of prolymphocytes in the bone marrow, spleen, and peripheral blood</li>
</ul>
</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Marked splenomegaly</li>
<li>Lymphadenopathy (less common than in CLL)</li>
<li>High WBC count</li>
<li>Fatigue</li>
<li>B symptoms (fever, weight loss, night sweats)</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>CBC:
<ul>
<li>Elevated WBC count (often &gt; 100 x 10^9/L)</li>
<li>Anemia</li>
<li>Thrombocytopenia</li>
</ul>
</li>
<li>Peripheral Blood Smear:
<ul>
<li>Predominance of prolymphocytes (typically &gt;55% of WBCs)
<ul>
<li>Prolymphocytes: Medium to large lymphocytes with a prominent nucleolus and moderately condensed chromatin</li>
</ul>
</li>
<li>Smudge cells are uncommon</li>
</ul>
</li>
<li>Immunophenotyping:
<ul>
<li>B-PLL: CD5-, CD19+, CD20+, CD22+, CD23 (variable), FMC7+, sIg (bright)</li>
<li>T-PLL: CD3+, CD4+ or CD8+, CD7+, CD5 (variable), CD26-</li>
</ul>
</li>
<li>Cytogenetic Analysis:
<ul>
<li>Common abnormalities: t(11;14)(q13;q32) in B-PLL; inv(14)(q11q32) or t(14;14)(q11;q32) in T-PLL</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Chemoimmunotherapy:
<ul>
<li>Alemtuzumab (anti-CD52 monoclonal antibody) in combination with chemotherapy</li>
</ul>
</li>
<li>Targeted Therapies:
<ul>
<li>BTK inhibitors (e.g., ibrutinib)</li>
</ul>
</li>
<li>Hematopoietic Stem Cell Transplantation (HSCT):
<ul>
<li>Potentially curative option</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="hairy-cell-leukemia-hcl" class="section level2 unnumbered">
<h2>
<strong>Hairy Cell Leukemia (HCL)</strong><a class="anchor" aria-label="anchor" href="#hairy-cell-leukemia-hcl"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A rare, indolent B-cell neoplasm characterized by infiltration of the bone marrow, spleen, and liver by small lymphocytes with “hairy” cytoplasmic projections</li>
<li>
<strong>Pathophysiology:</strong>
<ul>
<li>Clonal proliferation of mature B cells with distinct immunophenotype</li>
<li>Almost all cases have a <em>BRAF</em> V600E mutation</li>
<li>Cells infiltrate the bone marrow and spleen, leading to cytopenias and splenomegaly</li>
</ul>
</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Splenomegaly (often massive)</li>
<li>Pancytopenia (anemia, thrombocytopenia, neutropenia)</li>
<li>Fatigue</li>
<li>Infections</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>CBC:
<ul>
<li>Pancytopenia (variable severity)</li>
<li>Monocytopenia (almost always present)</li>
</ul>
</li>
<li>Peripheral Blood Smear:
<ul>
<li>Hairy cells: Small lymphocytes with irregular cytoplasmic projections (“hairy” appearance)</li>
</ul>
</li>
<li>Bone Marrow Aspiration and Biopsy:
<ul>
<li>Infiltration of the bone marrow by hairy cells</li>
<li>“Fried egg” appearance of hairy cells on biopsy</li>
</ul>
</li>
<li>Immunophenotyping:
<ul>
<li>CD19+, CD20+, CD22+, CD11c+, CD25+, CD103+</li>
<li>Annexin A1+</li>
</ul>
</li>
<li>Molecular Testing:
<ul>
<li>
<em>BRAF</em> V600E mutation</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Purine Analogs:
<ul>
<li>Cladribine (2-CdA) or pentostatin</li>
<li>Highly effective in inducing durable remissions</li>
</ul>
</li>
<li>Rituximab (anti-CD20 monoclonal antibody):
<ul>
<li>May be used as a single agent or in combination with purine analogs</li>
</ul>
</li>
<li>Splenectomy:
<ul>
<li>May be considered in patients with symptomatic splenomegaly or cytopenias that do not respond to other treatments</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="burkitt-lymphoma" class="section level2 unnumbered">
<h2>
<strong>Burkitt Lymphoma</strong><a class="anchor" aria-label="anchor" href="#burkitt-lymphoma"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A highly aggressive B-cell lymphoma characterized by rapid proliferation and a high rate of cell turnover</li>
<li>
<strong>Genetic Abnormality:</strong> Translocation involving the <em>MYC</em> gene on chromosome 8 (typically t(8;14)(q24;q32)), leading to overexpression of MYC, a transcription factor that promotes cell growth and proliferation</li>
<li>
<strong>Types:</strong>
<ul>
<li>Endemic Burkitt Lymphoma: Associated with Epstein-Barr virus (EBV) infection; common in Africa</li>
<li>Sporadic Burkitt Lymphoma: Not associated with EBV; occurs worldwide</li>
<li>Immunodeficiency-Associated Burkitt Lymphoma: Occurs in individuals with HIV/AIDS or other immunodeficiency states</li>
</ul>
</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Rapidly growing tumor mass, often involving the jaw, abdomen, or other extranodal sites</li>
<li>B symptoms (fever, weight loss, night sweats)</li>
<li>May present with bowel obstruction, abdominal pain, or other symptoms depending on the location of the tumor</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>CBC:
<ul>
<li>May show leukocytosis, anemia, or thrombocytopenia</li>
</ul>
</li>
<li>Peripheral Blood Smear:
<ul>
<li>May show “starry sky” pattern due to numerous macrophages engulfing apoptotic cells</li>
</ul>
</li>
<li>Bone Marrow Aspiration and Biopsy:
<ul>
<li>Infiltration of the bone marrow by Burkitt lymphoma cells</li>
</ul>
</li>
<li>Flow Cytometry Immunophenotyping:
<ul>
<li>CD19+, CD20+, CD10+, BCL6+, Ki-67 (proliferation marker) is very high (approaching 100%)</li>
<li>CD5-, CD23-</li>
</ul>
</li>
<li>Cytogenetic Analysis:
<ul>
<li>t(8;14)(q24;q32) or other <em>MYC</em> translocation</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Intensive Chemotherapy:
<ul>
<li>Short-duration, high-intensity chemotherapy regimens are used to rapidly eradicate the tumor cells</li>
<li>Examples: R-hyperCVAD, CODOX-M/IVAC</li>
</ul>
</li>
<li>CNS Prophylaxis:
<ul>
<li>Intrathecal chemotherapy to prevent CNS involvement</li>
</ul>
</li>
<li>Management of Tumor Lysis Syndrome (TLS):
<ul>
<li>Aggressive hydration, allopurinol, and rasburicase to prevent TLS</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="waldenström-macroglobulinemia-wm" class="section level2 unnumbered">
<h2>
<strong>Waldenström Macroglobulinemia (WM)</strong><a class="anchor" aria-label="anchor" href="#waldenstr%C3%B6m-macroglobulinemia-wm"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A rare, indolent B-cell lymphoma characterized by the presence of IgM monoclonal gammopathy and infiltration of the bone marrow and other tissues by lymphoplasmacytic cells</li>
<li>
<strong>Genetic Abnormality:</strong> Most cases have a mutation in <em>MYD88</em> gene</li>
<li>
<strong>Pathophysiology:</strong>
<ul>
<li>Clonal proliferation of lymphoplasmacytic cells (a mixture of lymphocytes and plasma cells) that secrete IgM antibodies</li>
<li>Accumulation of IgM in the serum can lead to hyperviscosity syndrome</li>
</ul>
</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Often asymptomatic</li>
<li>Fatigue</li>
<li>Weakness</li>
<li>Weight loss</li>
<li>Night sweats</li>
<li>Lymphadenopathy</li>
<li>Splenomegaly</li>
<li>Hyperviscosity Syndrome:
<ul>
<li>Blurred vision</li>
<li>Headache</li>
<li>Dizziness</li>
<li>Neuropathy</li>
<li>Bleeding</li>
</ul>
</li>
<li>Cryoglobulinemia:
<ul>
<li>Precipitation of IgM antibodies at low temperatures, leading to vascular symptoms (e.g., Raynaud phenomenon, purpura)</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>CBC:
<ul>
<li>Anemia</li>
<li>Thrombocytopenia (in some cases)</li>
<li>Leukocytosis or lymphocytosis (variable)</li>
</ul>
</li>
<li>Peripheral Blood Smear:
<ul>
<li>May show lymphoplasmacytic cells</li>
<li>Rouleaux formation (stacking of RBCs) due to increased serum protein</li>
</ul>
</li>
<li>Serum Protein Electrophoresis (SPEP):
<ul>
<li>IgM monoclonal spike</li>
</ul>
</li>
<li>Serum Immunofixation Electrophoresis (IFE):
<ul>
<li>Confirms the presence of IgM monoclonal gammopathy</li>
</ul>
</li>
<li>Bone Marrow Aspiration and Biopsy:
<ul>
<li>Infiltration of the bone marrow by lymphoplasmacytic cells</li>
</ul>
</li>
<li>Molecular Testing:
<ul>
<li>
<em>MYD88</em> L265P mutation (most common)</li>
<li>
<em>CXCR4</em> mutations (in some cases)</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Asymptomatic Patients:
<ul>
<li>Watchful waiting</li>
</ul>
</li>
<li>Symptomatic Patients:
<ul>
<li>Rituximab: Anti-CD20 monoclonal antibody</li>
<li>Chemotherapy: Cyclophosphamide, bendamustine</li>
<li>BTK Inhibitors: Ibrutinib, zanubrutinib</li>
<li>Proteasome Inhibitors: Bortezomib</li>
<li>Plasmapheresis: To remove IgM from the serum in hyperviscosity syndrome</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-31" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-31"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Lymphoid Neoplasm:</strong> Malignancy originating from lymphocytes</li>
<li>
<strong>Chronic Lymphocytic Leukemia (CLL):</strong> Indolent leukemia of mature B cells</li>
<li>
<strong>Small Lymphocytic Lymphoma (SLL):</strong> Lymphoma of mature B cells, similar to CLL</li>
<li>
<strong>Prolymphocytic Leukemia (PLL):</strong> Aggressive leukemia of prolymphocytes</li>
<li>
<strong>Hairy Cell Leukemia (HCL):</strong> Indolent leukemia of B cells with “hairy” cytoplasmic projections</li>
<li>
<strong>Burkitt Lymphoma:</strong> Highly aggressive lymphoma with a <em>MYC</em> translocation</li>
<li>
<strong>Waldenström Macroglobulinemia (WM):</strong> Lymphoma with IgM monoclonal gammopathy</li>
<li>
<strong>Immunophenotyping:</strong> Identification of cell surface markers using flow cytometry</li>
<li>
<strong>Cytogenetic Analysis:</strong> The study of chromosomes and their abnormalities</li>
<li>
<strong>B Symptoms:</strong> Fever, weight loss, night sweats</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script>
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
</script><div class="chapter-nav">
<div class="prev"><a href="acute-lymphoid.html">Acute Lymphoid</a></div>
<div class="next"><a href="chronic-t-cell.html">Chronic T-Cell</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#chronic-b-cell">Chronic B-Cell</a></li>
<li><a class="nav-link" href="#overview-of-chronicmature-b-cell-leukemialymphoma">Overview of Chronic/Mature B-Cell Leukemia/Lymphoma</a></li>
<li><a class="nav-link" href="#chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-cllsll">Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)</a></li>
<li><a class="nav-link" href="#prolymphocytic-leukemia-pll">Prolymphocytic Leukemia (PLL)</a></li>
<li><a class="nav-link" href="#hairy-cell-leukemia-hcl">Hairy Cell Leukemia (HCL)</a></li>
<li><a class="nav-link" href="#burkitt-lymphoma">Burkitt Lymphoma</a></li>
<li><a class="nav-link" href="#waldenstr%C3%B6m-macroglobulinemia-wm">Waldenström Macroglobulinemia (WM)</a></li>
<li><a class="nav-link" href="#key-terms-31">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Hematology/blob/main/02-13-leukocyte-neoplasia-lymphoid-chronic-b.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Hematology/edit/main/02-13-leukocyte-neoplasia-lymphoid-chronic-b.Rmd">Edit this page <i class="fab fa-github"></i></a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-02-23 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
